Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3

Abstract Background Midostaurin combined with chemotherapy is currently used to treat newly diagnosed acute myeloid leukemia (AML) patients with FMS-like tyrosine kinase 3 (FLT3)-mutations. However, midostaurin acts as an antagonist to some chemotherapeutic agents in leukemia cell lines without FLT3...

Full description

Bibliographic Details
Published in:	BMC Cancer
Main Authors:	Hao Lu, Xiang-qin Weng, Yan Sheng, Jing Wu, Hui-min Xi, Xun Cai
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Subjects:	Acute myeloid leukemia All-trans retinoic acid Apoptosis Differentiation Midostaurin
Online Access:	https://doi.org/10.1186/s12885-022-09828-2

Similar Items

Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.
by: Salvatore Perrone, et al.
Published: (2020-04-01)

Targeting FLT3 Mutations in Acute Myeloid Leukemia
by: Riad El Fakih, et al.
Published: (2018-01-01)

Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy
by: Bocchia M, et al.
Published: (2022-04-01)

Experience with FLT3 Inhibitor Midostaurin in Newly Diagnosed Acute Myeloid Leukemia Patients
by: Mehmet Baysal, et al.
Published: (2021-03-01)

FLT3 and IDH1/2 Inhibitors for Acute Myeloid Leukemia: Focused Clinical Narrative Review of Forthcoming Drugs from an Indian Context
by: Suvir Singh, et al.
Published: (2024-04-01)

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
by: Chiara Cattaneo, et al.
Published: (2022-05-01)

An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO‐based treatment
by: Romain Loyaux, et al.
Published: (2023-08-01)

Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment
by: Zheng Li, et al.
Published: (2022-02-01)

Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
by: Ida Sofie Grønningsæter, et al.
Published: (2019-10-01)

Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia
by: Zhichen Wei, et al.
Published: (2024-09-01)

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
by: Etienne Paubelle, et al.
Published: (2019-05-01)

A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice
by: Monica Messina, et al.
Published: (2024-12-01)

Targeted therapy of newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. A single-center ambispective cohort study
by: N. K. Pastukhov, et al.
Published: (2025-03-01)

All -Trans-Retinoic Acid–induced pseudotumor cerebri in Acute Promyelocytic Leukemia
by: anoop tm
Published: (2014-08-01)

A Rare Complication in a Patient with Acute Promyelocytic Leukemia; ATRA and Posaconazole Associated Hypercalcemia
by: Yeşim Yiğit, et al.
Published: (2024-09-01)

Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemiaResearch in context
by: Weronika E. Borek, et al.
Published: (2024-10-01)

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2018-09-01)

Multiplexed single‐cell mass cytometry reveals distinct inhibitory effects on intracellular phosphoproteins by midostaurin in combination with chemotherapy in AML cells
by: Emma Rörby, et al.
Published: (2021-02-01)

Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
by: Øystein Bruserud, et al.
Published: (2021-05-01)

Acute promyelocytic leukemia in children cancer hospital Egypt
by: Samah Semary, et al.
Published: (2024-06-01)

A case of acute promyelocytic leukemia with morphologic multilineage dysplastic changes
by: Setsuki Isono, et al.
Published: (2013-02-01)

History of Acute Promyelocytic Leukemia
by: Miguel A. Sanz, et al.
Published: (2021-07-01)

Post‐stem cell transplant maintenance in FLT3mut acute myeloid leukemia – A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib
by: Karam Ashouri, et al.
Published: (2024-04-01)

Case Report: Molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level
by: Meng-Ke Liu, et al.
Published: (2023-08-01)

Recurrent Hyperbilirubinemia with Midostaurin during Consolidation in a Patient of AML with FLT3 Mutation and Review of Literature for Alternative Maintenance Strategy
by: Deepak Kumar Shukla, et al.
Published: (2025-08-01)

Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
by: Jacopo Albanesi, et al.
Published: (2020-11-01)

Acute Promyelocytic Leukemia: Simplifying Treatment in a Resource Poor Setting
by: Rohan Bhise, et al.
Published: (2021-10-01)

Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis
by: Renata Cabral, et al.
Published: (2014-11-01)

Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF
by: Liu D, et al.
Published: (2024-07-01)

Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment
by: Federico Angriman, et al.
Published: (2015-05-01)

What Happened Suddenly - Acute Abdomen? A Difficult Case of ATRA-Related Pneumatosis Cystoides Intestinalis
by: Merve Ecem Erdoğan Yön, et al.
Published: (2025-06-01)

Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report
by: Xianfeng Ouyang, et al.
Published: (2025-05-01)

TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT
by: Cristina Papayannidis, et al.
Published: (2022-10-01)

TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT
by: Cristina Papayannidis, et al.
Published: (2022-10-01)

Scrotal ulceration following all-trans retinoic acid therapy for acute promyelocytic leukemia
by: Illias Tazi, et al.
Published: (2011-01-01)

All-Trans Retinoic Acid-Induced Ototoxicity during Chemotherapy in Pediatric Acute Promyelocytic Leukemia
by: Jong Hyeon Lee, et al.
Published: (2021-01-01)

Acute Promyelocytic Leukemia in Four Year Old Female Child - A Case Report
by: Anirudha V. Kushtagi, et al.
Published: (2014-07-01)

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
by: Damla Ortaboz, et al.
Published: (2023-03-01)

Leucemia promielocítica de reciente diagnóstico. Tratamiento con trióxido de arsénico de producción nacional (Arsenin®)
by: Carlos Hernández Padrón, et al.

Pancreatitis in acute promyelocytic leukemia: Drug-induced or differentiation syndrome?
by: Dibyendu De, et al.
Published: (2017-01-01)